Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249

Article  PubMed  Google Scholar 

Chevallay M, Bollschweiler E, Chandramohan SM et al (2018) Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci 1434:132–138

Article  ADS  PubMed  Google Scholar 

Thrift AP, Whiteman DC (2012) The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol: Off J Eur Soc Med Oncol 23:3155–3162

Article  CAS  Google Scholar 

Matsuno K, Ishihara R, Ohmori M et al (2019) Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. J Gastroenterol 54:784–791

Article  CAS  PubMed  Google Scholar 

Hatta W, Tong D, Lee YY et al (2017) Different time trend and management of esophagogastric junction adenocarcinoma in three Asian countries. Dig Endosc 29(Suppl 2):18–25

Article  PubMed  Google Scholar 

Liu K, Yang K, Zhang W et al (2016) Changes of esophagogastric junctional adenocarcinoma and gastroesophageal reflux disease among surgical patients during 1988–2012: a single-institution, high-volume experience in China. Ann Surg 263:88–95

Article  PubMed  Google Scholar 

Ajani JA, D’Amico TA, Bentrem DJ et al (2022) Gastric Cancer, Version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw: JNCCN 20:167–192

Article  CAS  PubMed  Google Scholar 

Alsina M, Arrazubi V, Diez M et al (2023) Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat Rev Gastroenterol Hepatol 20:155–170

Article  CAS  PubMed  Google Scholar 

Shah MA, Kennedy EB, Alarcon-Rozas AE et al (2023) Immunotherapy and targeted therapy for advanced gastroesophageal cancer: ASCO guideline. J Clin Oncol 41:1470–1491

Article  CAS  PubMed  Google Scholar 

Wu T, Dai Y (2017) Tumor microenvironment and therapeutic response. Cancer Lett 387:61–68

Article  CAS  PubMed  Google Scholar 

Giraldo NA, Sanchez-Salas R, Peske JD et al (2019) The clinical role of the TME in solid cancer. Br J Cancer 120:45–53

Article  PubMed  Google Scholar 

Mao X, Xu J, Wang W et al (2021) Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 20:131

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez-Outschoorn UE, Lisanti MP, Sotgia F (2014) Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin Cancer Biol 25:47–60

Article  CAS  PubMed  Google Scholar 

Kobayashi H, Enomoto A, Woods SL et al (2019) Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol 16:282–295

Article  PubMed  Google Scholar 

Farhood B, Najafi M, Mortezaee K (2019) Cancer-associated fibroblasts: secretions, interactions, and therapy. J Cell Biochem 120:2791–2800

Article  CAS  PubMed  Google Scholar 

Chen Y, McAndrews KM, Kalluri R (2021) Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol 18:792–804

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vangangelt KMH, Green AR, Heemskerk IMF et al (2020) The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer. Int J Cancer 146:2296–2304

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kramer CJH, Vangangelt KMH, van Pelt GW et al (2019) The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review. Breast Cancer Res Treat 173:55–64

Article  CAS  PubMed  Google Scholar 

Ueno H, Kanemitsu Y, Sekine S et al (2017) Desmoplastic pattern at the tumor front defines poor-prognosis subtypes of colorectal cancer. Am J Surg Pathol 41:1506–1512

Article  PubMed  Google Scholar 

Akimoto N, Väyrynen JP, Zhao M et al (2022) Desmoplastic reaction, immune cell response, and prognosis in colorectal cancer. Front Immunol 13:840198

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng C, Liu J, Yang G et al (2018) The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system. J Gastroenterol 53:606–617

Article  PubMed  Google Scholar 

Yim K, Jang WM, Cho U et al (2022) Intratumoral budding in pretreatment biopsies, among tumor microenvironmental components, can predict prognosis and neoadjuvant therapy response in colorectal adenocarcinoma. Medicina (Kaunas, Lithuania) 58

Liang Y, Zhu Y, Lin H et al (2021) The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study. BMC Cancer 21:729

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen X, Zee SY, Shroyer KR et al (2022) Intratumoral budding and tumor microenvironment in pretreatment rectal cancer biopsies predict the response to neoadjuvant chemoradiotherapy. Appl Immunohistochem Mol Morphol : AIMM 30:1–7

Article  CAS  PubMed  Google Scholar 

van Pelt GW, Krol JA, Lips IM et al (2020) The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer. Clin Transl Radiat Oncol 20:39–44

PubMed  Google Scholar 

Bruni D, Angell HK, Galon J (2020) The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer 20:662–680

Article  CAS  PubMed  Google Scholar 

Chen DS, Mellman I (2017) Elements of cancer immunity and the cancer-immune set point. Nature 541:321–330

Article  ADS  CAS  PubMed  Google Scholar 

Yu CC, Wortman JC, He TF et al (2021) Physics approaches to the spatial distribution of immune cells in tumors. Rep Progress Phys Phys Soc (Great Britain) 84:022601

Article  ADS  CAS  Google Scholar 

Huang Q, Read M, Gold JS et al (2020) Unraveling the identity of gastric cardiac cancer. J Dig Dis 21:674–686

Article  CAS  PubMed  Google Scholar 

van Pelt GW, Kjær-Frifeldt S, van Krieken J et al (2018) Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations. Virchows Archiv : Int J Pathol 473:405–412

Article  Google Scholar 

Kemi N, Eskuri M, Kauppila JH (2019) Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis. Sci Rep 9:16018

Article  ADS  PubMed  PubMed Central  Google Scholar 

Kemi NA, Eskuri M, Pohjanen VM et al (2019) Histological assessment of stromal maturity as a prognostic factor in surgically treated gastric adenocarcinoma. Histopathology 75:882–889

Article  PubMed  Google Scholar 

Ueno H, Ishiguro M, Nakatani E et al (2021) Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a phase 3 study (SACURA Trial). Br J Cancer 124:1088–1097

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ueno H, Jones A, Jass JR et al (2002) Clinicopathological significance of the ‘keloid-like’ collagen and myxoid stroma in advanced rectal cancer. Histopathology 40:327–334

Article  CAS  PubMed  Google Scholar 

Janjigian YY, Shitara K, Moehler M et al (2021) First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet (London, England) 398:27–40

Article  CAS  PubMed  Google Scholar 

Rha SY, Oh DY, Yañez P et al (2023) Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol 24:1181–1195

Article  CAS  PubMed  Google Scholar 

Klintrup K, Mäkinen JM, Kauppila S et al (2005) Inflammation and prognosis in colorectal cancer. Eur J Cancer (Oxford, England: 1990) 41:2645–2654

Article  Google Scholar 

Mandard AM, Dalibard F, Mandard JC et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic Correl Cancer 73:2680–2686

CAS  Google Scholar 

Koh YW, Park YS, Ryu MH et al (2013) Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy. Am J Surg Pathol 37:1022–1029

Article